Mirna Lechpammer
Overview
Explore the profile of Mirna Lechpammer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Lechpammer M, Todd A, Tang V, Morningstar T, Borowsky A, Shahlaie K, et al.
Brain Sci
. 2024 Jan;
14(1).
PMID: 38275528
Whereas traditional histology and light microscopy require multiple steps of formalin fixation, paraffin embedding, and sectioning to generate images for pathologic diagnosis, Microscopy using Ultraviolet Surface Excitation (MUSE) operates through...
3.
Gupta A, Lechpammer M, Brossier N
Childs Nerv Syst
. 2024 Jan;
40(5):1609-1612.
PMID: 38168858
Background: BRCA1 and BRCA2 are tumor suppressor genes associated with increased risk of breast and ovarian cancer in adulthood. Patients with germline pathogenic variants in these genes have also been...
4.
Haberberger J, Pegram W, Britt N, Schiavone K, Severson E, Sharaf R, et al.
Oncologist
. 2023 Aug;
29(1):e47-e58.
PMID: 37619245
The authors present a cohort of 661 young adult glioblastomas diagnosed using 2016 WHO World Health Organization Classification of Tumors of the Central Nervous System, utilizing comprehensive genomic profiling (CGP)...
5.
Hiemenz M, Kaur J, Kuang Z, Huang R, Harries L, Metzger D, et al.
Genes Chromosomes Cancer
. 2023 Mar;
62(8):460-470.
PMID: 36862145
Gene fusions involving EWSR1 or FUS as the 5' partner have been reported in a diverse array of sarcomas. Here, we characterize the histopathology and genomics of six tumors harboring...
6.
Lechpammer M, Mahammedi A, Pomeranz Krummel D, Sengupta S
Handb Clin Neurol
. 2023 Feb;
192:131-140.
PMID: 36796938
Glioblastoma (GBM) is the most common and aggressive malignant adult brain tumor. Significant effort has been directed to achieve a molecular subtyping of GBM to impact treatment. The discovery of...
7.
Severson E, Haberberger J, Hemmerich A, Huang R, Edgerly C, Schiavone K, et al.
Oncologist
. 2022 Nov;
28(1):e26-e35.
PMID: 36342081
Background: B-cell primary central nervous system (CNS) lymphoma (PCL) is diffuse large B-cell lymphoma (DLBCL) confined to the CNS. Less than 50% of patients with PCL achieve complete remission with...
8.
Ladenheim A, Mitra A, Lechpammer M, Dwyre D
Surg Neurol Int
. 2022 Jul;
13:267.
PMID: 35855153
Background: Extramedullary hematopoiesis (EMH) and plasmacytomas occurring within the cranium are rare entities. Case Description: We review two cases in which patients presented with subdural hematoma and underwent evacuation. On...
9.
Lechpammer M, Rao R, Shah S, Mirheydari M, Bhattacharya D, Koehler A, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406398
Glioblastoma, or glioblastoma multiforme (GBM, WHO Grade IV), is a highly aggressive adult glioma. Despite extensive efforts to improve treatment, the current standard-of-care (SOC) regimen, which consists of maximal resection,...
10.
Lin D, Fine A, Danziger N, Huang R, Mata D, Decker B, et al.
Gynecol Oncol
. 2022 Jan;
164(3):558-565.
PMID: 34998597
Objectives: Endometrial serous carcinoma (EMSC) is an aggressive variant of uterine cancer with limited therapeutic options. We sought to define distinct clinicopathologic and genomic EMSC subgroups. Methods: We retrospectively analyzed...